Zdrowie i gospodarka · 01/06/2020

FDA Establishes Public Docket for Orange Book Comments

The Food and Drug Administration (FDA) is launching a public docket to gather comments on its 'Orange Book', a publication that lists approved drug products and their therapeutic equivalences. The FDA aims to improve transparency and gather feedback on the book's usefulness to the public and regulated industries.